Literature DB >> 19345433

Bayesian and classical estimation of mixed logit: An application to genetic testing.

Dean A Regier1, Mandy Ryan, Euan Phimister, Carlo A Marra.   

Abstract

Discrete choice experiments (DCEs) in health economics have recently used the mixed logit (MXL) model to incorporate preference heterogeneity. These studies typically use a classical approach to estimation or have specified normal distributions for the attributes. Specifying normal distributions can lead to erroneous interpretation; non-normal distributions may cause problems with convergence to the global maximum of the simulated log-likelihood function. Hierarchical Bayes (HB) of MXL is an alternative estimation approach that may alleviate problems of convergence. We investigated Bayesian and classical approaches to MXL estimation using a DCE that elicited preferences for a genetic technology. The classical approach produced unrealistic results in one of the econometric specifications, which led to an erroneous willingness to pay estimate. The HB procedure produced reasonable results for both specifications and helped ascertain that the classical procedures were converging at a local maximum.

Mesh:

Year:  2008        PMID: 19345433     DOI: 10.1016/j.jhealeco.2008.11.003

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  16 in total

1.  Population preferences for health care in liberia: insights for rebuilding a health system.

Authors:  Margaret E Kruk; Peter C Rockers; S Tornorlah Varpilah; Rose Macauley
Journal:  Health Serv Res       Date:  2011-04-21       Impact factor: 3.402

2.  Family-based genetic risk prediction of multifactorial disease.

Authors:  Douglas M Ruderfer; Joshua Korn; Shaun M Purcell
Journal:  Genome Med       Date:  2010-01-15       Impact factor: 11.117

3.  Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experiments.

Authors:  Franziska Severin; Jörg Schmidtke; Axel Mühlbacher; Wolf H Rogowski
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

4.  Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.

Authors:  Dean A Regier; Stuart J Peacock; Reka Pataky; Kimberly van der Hoek; Gail P Jarvik; Jeffrey Hoch; David Veenstra
Journal:  CMAJ       Date:  2015-03-09       Impact factor: 8.262

5.  The price of whole-genome sequencing may be decreasing, but who will be sequenced?

Authors:  Deborah A Marshall; Karen V MacDonald; Jill Oliver Robinson; Lisa F Barcellos; Milena Gianfrancesco; Monica Helm; Amy McGuire; Robert C Green; Michael P Douglas; Michael A Goldman; Kathryn A Phillips
Journal:  Per Med       Date:  2017-05-23       Impact factor: 2.512

Review 6.  Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.

Authors:  Katrina A B Goddard; William A Knaus; Evelyn Whitlock; Gary H Lyman; Heather Spencer Feigelson; Sheri D Schully; Scott Ramsey; Sean Tunis; Andrew N Freedman; Muin J Khoury; David L Veenstra
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

7.  Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).

Authors:  Caroline Savage Bennette; Susan Brown Trinidad; Stephanie M Fullerton; Donald Patrick; Laura Amendola; Wylie Burke; Fuki M Hisama; Gail P Jarvik; Dean A Regier; David L Veenstra
Journal:  Genet Med       Date:  2013-05-30       Impact factor: 8.822

8.  And When I Die: Theory of Planned Behavior as Applied to Sperm Cryopreservation.

Authors:  Limor Dina Gonen
Journal:  Healthcare (Basel)       Date:  2021-05-09

9.  Moving Toward Patient-Centered Care in Africa: A Discrete Choice Experiment of Preferences for Delivery Care among 3,003 Tanzanian Women.

Authors:  Elysia Larson; Daniel Vail; Godfrey M Mbaruku; Angela Kimweri; Lynn P Freedman; Margaret E Kruk
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran.

Authors:  Enayatollah Homaie Rad; Mohammad Hajizadeh; Vahid Yazdi-Feyzabadi; Sajad Delavari; Zahra Mohtasham-Amiri
Journal:  Appl Health Econ Health Policy       Date:  2021-07-27       Impact factor: 2.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.